+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

CAR-T Cell Therapies: Intellectual Property Landscape (Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claims Analysis) - Product Thumbnail Image

CAR-T Cell Therapies: Intellectual Property Landscape (Featuring Historical and Contemporary Patent Filing Trends, Prior Art Search Expressions, Patent Valuation Analysis, Patentability, Freedom to Operate, Pockets of Innovation, Existing White Spaces, and Claims Analysis)

  • Report
  • April 2022
  • 116 Pages
  • Global
From
Global T-Cell (CAR-T, TCR, and TIL) Therapy Market (4th Edition), 2019-2030 - Product Thumbnail Image

Global T-Cell (CAR-T, TCR, and TIL) Therapy Market (4th Edition), 2019-2030

  • Report
  • July 2019
  • 800 Pages
  • Global
From
Atherosclerosis Drugs Global Market Report 2024 - Product Thumbnail Image

Atherosclerosis Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Pericarditis Global Market Report 2024 - Product Thumbnail Image

Pericarditis Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Eylea Global Market Report 2024 - Product Thumbnail Image

Eylea Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Pharmaceutical Contract Development and Manufacturing Organization (CMO) Global Market Report 2024 - Product Thumbnail Image

Pharmaceutical Contract Development and Manufacturing Organization (CMO) Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Central Serous Chorioretinopathy - Pipeline Insight, 2024 - Product Thumbnail Image

Central Serous Chorioretinopathy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Facial Erythema Treatment Market 2022-2026 - Product Thumbnail Image

Facial Erythema Treatment Market 2022-2026

  • Report
  • February 2022
  • 120 Pages
  • Global
From
Acute Coronary Syndrome Global Market Report 2024 - Product Thumbnail Image

Acute Coronary Syndrome Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Inotropic Agents Global Market Report 2024 - Product Thumbnail Image

Inotropic Agents Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Fibromyalgia Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Fibromyalgia Treatment Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 160 Pages
  • Global
From
Cataract - Pipeline Insight, 2024 - Product Thumbnail Image

Cataract - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Atherosclerotic Cardiovascular Disease (ASCVD) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Atherosclerotic Cardiovascular Disease (ASCVD) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • October 2024
  • 249 Pages
  • Global
From
Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics), End user (Pharmaceutical, Biotechnology, Academia) - Global Forecast to 2026 - Product Thumbnail Image

Genome Editing/Genome Engineering Market by Technology (CRISPR, TALEN, ZFN, Antisense), Product & Service, Application (Cell Line Engineering, Genetic Engineering, Diagnostics), End user (Pharmaceutical, Biotechnology, Academia) - Global Forecast to 2026

  • Report
  • November 2021
  • 201 Pages
  • Global
From
Fibrodysplasia ossificans progressiva - Pipeline Insight, 2024 - Product Thumbnail Image

Fibrodysplasia ossificans progressiva - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
PD-1 And PD-L1 Inhibitors - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

PD-1 And PD-L1 Inhibitors - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 160 Pages
  • Global
From
Familial Hypercholesterolemia - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Familial Hypercholesterolemia - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Ethical Pharmaceuticals Global Market Report 2024 - Product Thumbnail Image

Ethical Pharmaceuticals Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
Controlled Substance Global Market Report 2024 - Product Thumbnail Image

Controlled Substance Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Lipodystrophy - Pipeline Insight, 2024 - Product Thumbnail Image

Lipodystrophy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator